News & Insights

Pioneer in the transcatheter treatment of aortic regurgitation (AR), JenaValve Technology, announces its agreement to be acquired by Edwards Lifesciences

Developer of pioneering technologies to empower science, Element Biosciences, announces its $277 million Series D financing led by Wellington Management

Clinical stage biopharmaceutical company, Contineum Therapeutics, announces the pricing of its initial public offering of 6,875,000 shares of its Class A common stock at a price to the public of $16.00 per share.

Best Lawyers recognizes 38 Gunderson Dettmer attorneys across both the 2026 editions of The Best Lawyers in America list and Best Lawyers: Ones to Watch in America, continuing the legacy of celebrating exceptional legal professionals who have distinguished themselves through insight, expertise, and commitment to excellence